Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
1,983
Views
1
CrossRef citations to date
0
Altmetric
Neurology

Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden

Carlos Acostaa Value & Market Access, Biogen International GmbH, Baar, SwitzerlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7257-8675
ORCID Icon,
Mattia Gianinazzia Value & Market Access, Biogen International GmbH, Baar, Switzerland
,
Thibaut Dorta Value & Market Access, Biogen International GmbH, Baar, Switzerland
,
Nigel Armstrongb Kleijnen Systematic Reviews, Ltd., York, UK
,
Steve Ryderb Kleijnen Systematic Reviews, Ltd., York, UK
,
Thomas Lundqvistc Market Access, Biogen Sweden AB, Upplands Väsby, Sweden
,
Mats Ekelundc Market Access, Biogen Sweden AB, Upplands Väsby, Sweden
&
Jan Lycked Institute of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden
 show all
Pages 770-780 | Received 22 Feb 2021, Accepted 06 May 2021, Published online: 21 Jun 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.